HomeBFRIW • NASDAQ
add
Biofrontera
Market news
Financials
Income Statement
Revenue
Net income
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 3.71M | -35.97% |
Operating expense | 4.11M | -24.06% |
Net income | -2.71M | 22.07% |
Net profit margin | -72.93 | -21.71% |
Earnings per share | — | — |
EBITDA | -1.57M | -92.43% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.64M | -50.14% |
Total assets | 28.04M | 4.22% |
Total liabilities | 10.78M | 7.46% |
Total equity | 17.26M | — |
Shares outstanding | 3.04M | — |
Price to book | 0.01 | — |
Return on assets | -13.82% | — |
Return on capital | -20.60% | — |
Cash Flow
Net change in cash
(EUR) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -2.71M | 22.07% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1997
Website
Employees
97